Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-107.28%
↓ 118% below average
Average (9y)
612.60%
Historical baseline
Range
High:2103.39%
Low:-157.23%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -107.28% |
| 2023 | 252.53% |
| 2022 | -157.23% |
| 2021 | 2022.22% |
| 2020 | -100.54% |
| 2019 | 455.87% |
| 2018 | 893.33% |
| 2017 | 864.33% |
| 2016 | -100.60% |
| 2015 | 2103.39% |